Lapidus Stanley 4
4 · Lucid Diagnostics Inc. · Filed Sep 22, 2022
Insider Transaction Report
Form 4
Lapidus Stanley
Director
Transactions
- Sale
Common stock
2022-09-20$1.70/sh−16,864$28,669→ 135,456 total - Sale
Common stock
2022-09-20$1.71/sh−17,000$29,014→ 152,320 total
Footnotes (2)
- [F1]Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock.
- [F2]Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which will vest September 20, 2023. Under the plan, unvested shares are subject to forfeiture if the requisite service period is not completed.